GFAP Polyclonal Antibody

GFAP encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms.

The GFAP Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of glial fibrillary acidic protein (GFAP) in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards GFAP.

GFAP is an intermediate filament protein predominantly expressed in astrocytes, making it a valuable marker for astrocyte activation and gliosis. The GFAP Polyclonal Antibody has been extensively validated for its performance in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) applications.

With its exceptional sensitivity and low background, this antibody enables accurate and reliable detection of GFAP in both normal and pathological tissues. It offers researchers a powerful tool for studying astrocyte biology, neurodegenerative diseases, and various neurological disorders.

The GFAP Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is available in various sizes to accommodate different experimental needs. Each batch of antibody undergoes rigorous quality control testing to ensure consistent performance and reproducibility.

Choose the GFAP Polyclonal Antibody for its exceptional specificity, sensitivity, and reliability, and unlock new insights into the intricate world of astrocyte biology and neurological research.